STENT IMPLANTATION FOR RELIEF OF EARLY POSTOPERATIVE
STENOSIS OF BLALOCK-TAUSSIG-SHUNTS
Peuster M, Fink C, Paul T, Bertram H, Hausdorf G
Department of Pediatric Cardiology and Pediatric Intensive Care
Hannover Medical School, Germany
OBJECTIVE: The
use of the modified Blalock-Taussig shunt (MBTS) in the treatment of pulmonary
oligemia in patients with cyanotic congenital heart disease is well
established. Stenosis of the MBTS is a serious complication and its occurence
requires rapid and effective therapy. Often reoperation is needed to restore
sufficient pulmonary blood flow. We report on 3 patients with early
postoperative stenosis of the MBTS who were treated successfully with balloon
dilatation and stent implantation.
CASE REPORTS:
6 week old baby with tetralogy of fallot and hypoplastic pulmonary
arteries was palliated at 4 weeks of age with a MBTS. Postoperatively farther
hypoxemic spells were observed, cardiac catheterization revealed stenosis of
the MBTS at the insertion into the right pulmonary artery. After balloon
dilatation of the stenosis a GR II Flex stent was implanted. Angiography after
4 months demonstrated a patent MBTS. A 75 days old ne-wborn with
tricuspid- and pulmonary atresia was palliated at 10 days of age with a MBTS.
After prostaglandin e) was
discontinued arterial oxygen saturation dropped. Cardiac catheterization showed
a complete thrombosis of the MBTS. Balloon dilatation was performed. Due to the
irregular lumen of the MBTS a Palmaz-stent was implanted. 6 months
postinterventionally angiography demonstrated an unrestricted flow across the
MBTS. A 3 week old baby with pulmonary atresia and ventricular septal
defect was palliated with a MBTS at 5 days of age. Postoperatively arterial
oxygen saturations dropped. Stenosis of the subclavian artery proximally to the
MBTS was diagnosed. Balloon dilatation of the stenosis and implantation of a
Palmaz stent was performed. Angiography 3 months postinterventionally
demonstrated an unrestricted flow accross the MBTS.
CONCLUSION: In
patients with stenosis or thrombosis of MBTS balloon angioplasty and stent
implantation can be an effective alternative to fibrinolytic therapy or surgical
revision of the shunt.